Prather April, Aifaoui Aissa, Shaman Jeffrey A
Clinical Pharmacy, Know Your Rx Coalition, Lexington, USA.
Clinical Sciences, Coriell Life Sciences, Philadelphia, USA.
Cureus. 2022 Feb 2;14(2):e21834. doi: 10.7759/cureus.21834. eCollection 2022 Feb.
Clinical manifestations of biological aging can be remarkably similar to the side effects of frequently used medications. Fatigue, muscle pain, and confusion are common and often not shared as part of proper geriatric patient history. When patients report them, a root cause is usually confounding. These symptoms not only negatively impact health and wellness outcomes, patient quality of life, and increase costs to the healthcare system, but also may be a limitation on provider best practices. The patient, a 71-year-old female of European descent, enrolled in pharmacogenomics-enriched comprehensive medication management (PGx+CMM) program through her retirement benefit. At the time of testing, she was approximately 18 months post cerebrovascular accident and was being observed by her primary care provider for common chronic conditions. Of interest, she had been manifesting unreported clinical symptoms of fatigue, hypotension, and myalgia. Addressing these patient concerns and specifically focusing on an individual's goals, fears, and basic needs, rather than concentrating merely on the absence of disease, is the crux of personalized medicine and programs that address the notion of healthy aging. The patient's therapeutic regimen was adjusted based on PGx+CMM pharmacist review, use of a clinical decision support system (CDSS), and communication of recommendations to the prescribing physician. The patient saw rapid improvements in symptoms, suggesting they were caused by medication side effects. Her blood pressure and cholesterol levels remained controlled while noticeable side effects were eliminated. This case study demonstrates the positive impacts of personalized medicine and shows how pharmacists can be empowered with a CDSS to positively impact healthcare.
生物衰老的临床表现可能与常用药物的副作用极为相似。疲劳、肌肉疼痛和意识模糊很常见,且在老年患者的正常病史中通常不会提及。当患者报告这些症状时,通常很难找到根本原因。这些症状不仅会对健康和幸福状况、患者生活质量产生负面影响,增加医疗系统的成本,还可能限制医疗服务提供者的最佳实践。该患者是一名71岁的欧洲裔女性,通过其退休福利参加了药物基因组学强化综合药物管理(PGx+CMM)项目。在进行检测时,她脑血管意外后约18个月,其初级保健提供者正在观察她的常见慢性病情况。有趣的是,她一直表现出未报告的疲劳、低血压和肌痛等临床症状。关注这些患者的问题,特别是关注个人的目标、恐惧和基本需求,而不仅仅关注疾病的不存在,是个性化医疗以及解决健康老龄化概念的项目的关键。根据PGx+CMM药剂师的评估、临床决策支持系统(CDSS)的使用以及向开处方医生传达建议,对患者的治疗方案进行了调整。患者的症状迅速改善,表明这些症状是由药物副作用引起的。她的血压和胆固醇水平保持在可控范围内,同时明显的副作用也消除了。本案例研究展示了个性化医疗的积极影响,并说明了药剂师如何通过CDSS获得授权,从而对医疗保健产生积极影响。